LKT Labs

Biochemicals for Life Science Research

Eupatilin

Eupatilin

Product ID E8260
Cas No. 22368-21-4
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $138.70 Please Inquire
25 mg $555.00 Please Inquire
Bulk Quote

Quicklinks

Description

Eupatilin is an O-methylated flavone found in Artemisia; it exhibits anticancer chemotherapeutic, nephroprotective, anti-inflammatory, anti-arthritic, antinociceptive, gastrointestinal motility modulating, antidepressant, antioxidative, neuroprotective, and anti-angiogenic activities. In gastric cancer cells, eupatilin suppresses cell growth; in animal models of gastric cancer, eupatilin inhibits STAT3 and VEGF expression and decreases tumor growth. This compound activates PPARα and ameliorates kidney injury in models of renal ischemia/reperfusion. Additionally, eupatilin inhibits cartilage degradation, decreases nociception, and downregulates expression of IL-6, iNOS, and IL-1β in animal models of osteoarthritis. Eupatilin also slows gastrointestinal motility in animal models, protects against cerebral ischemia/reperfusion-induced neuronal damage, and decreases immobility time in animals undergoing the forced swim test.

Product Info

Cas No.

22368-21-4
Purity

≥98%
Formula

C18H16O7
Formula Wt.

344.32
Chemical Name

2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one
IUPAC Name

2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one
Synonym

NSC 122413; Stillen
Solubility

Soluble in DMSO, hot methanol or mixture of methanol and chloroform.
Appearance

Pale yellow powder.

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

E8260 MSDS PDF
Info Sheet

E8260 Info Sheet PDF

References

Choi Y, Jung Y, Kim SN. Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS. Molecules. 2015 Jul 28;20(8):13753-63. PMID: 26225954.

Jeong JH, Moon SJ, Jhun JY, et al. Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes. PLoS One. 2015 Jun 17;10(6):e0130882. PMID: 26083352.

Jeong HJ, Kim JH, Kim NR, et al. Antidepressant effect of Stillen. Arch Pharm Res. 2015 Jun;38(6):1223-31. PMID: 25163682.

Jeong EK, Jang HJ, Kim SS, et al. Protective effect of eupatilin against renal ischemia-reperfusion injury in mice. Transplant Proc. 2015 Apr;47(3):757-62. PMID: 25891726.

Ryoo SB, Oh HK, Yu SA, et al. The effects of eupatilin (stillen®) on motility of human lower gastrointestinal tracts. Korean J Physiol Pharmacol. 2014 Oct;18(5):383-90. PMID: 25352757.

Park BB, Yoon Js, Kim Es, et al. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells. Tumour Biol. 2013 Apr;34(2):875-85. PMID: 23292941.

Lim JC, Park SY, Nam Y, et al. The Protective Effect of Eupatilin against Hydrogen Peroxide-Induced Injury Involving 5-Lipoxygenase in Feline Esophageal Epithelial Cells. Korean J Physiol Pharmacol. 2012 Oct;16(5):313-20. PMID: 23118554.

Cai M, Phan PT, Hong JG, et al. The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice. Eur J Pharmacol. 2012 Aug 15;689(1-3):104-10. PMID: 22683875.

Cheong JH, Hong SY, Zheng Y, et al. Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression. J Gastric Cancer. 2011 Mar;11(1):16-22. PMID: 22076197.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P5747

    Polymyxin B sulfate

    Cationic lipid polypeptide, mixture of polymyxin B...
    ≥6500 iu/mg
  • C1601

    Carcinoembryonic Antigen (605-613) analog

    Carcinoembryonic antigen epitope analog.
    ≥95%
  • T3101

    Thyrotropin-releasing Hormone

    Endogenous tripeptide, involved in HPA signaling; ...
    ≥95%
  • A5225

    α-ANP (1-28), human

    Endogenous cardiomodulatory peptide; NPR-A agonist...
    ≥95%
  • C5196

    C-Myc Peptide

    Peptide, C-Myc fragment, used in protein activity ...
    ≥95%
  • S3352

    Sinefungin

    S-adenosylmethionine nucleoside analog; methyltran...
    ≥95%
  • A1369

    Adrenomedullin (13-52), human

    Endogenous peptide hormone, involved in cell growt...
    ≥95%
  • A7461

    Asperosaponin VI

    Triterpene saponin found in Dipsacus asper.
    ≥98%
  • L9609

    Lycopene

    Carotene pigment found in red and green fruits and...
    ≥90%
  • A2500

    AG-1478

    EGFR inhibitor.
    ≥98%
  • H9716

    (E,Z)-4-Hydroxytamoxifen

    Selective estrogen receptor modulator.
    ≥97%
  • M5793

    Moxifloxacin Free Base

    Fluoroquinolone; topoisomerase IV, topoisomerase I...
    ≥98%
  • T3132

    Thiazovivin

    ROCK inhibitor.
    ≥98%
  • D5747

    Dolasetron Mesylate Hydrate

    5-HT3 antagonist.
    ≥98%
  • H5748

    D,L-Homocysteine Thiolactone Hydrochloride

    Heterocyclic derivative of cysteine, alters protei...
    ≥98%
  • A7657

    Atosiban Acetate

    Peptide, alters uterine contractility; V1/2 and OX...
    ≥95%
  • H1657

    Heparin-binding Peptide

    Peptide, binds heparin.
    ≥95%
  • P6901

    Pramipexole Dihydrochloride

    D2/3 agonist.
    ≥98%
  • L0249

    Laminin Peptide YIGSR-NH2

    Laminin-derived peptapeptide.
    ≥98%
  • I5208

    INCB-28060

    c-MET inhibitor.
    ≥98%